Article Details
Retrieved on: 2022-09-20 15:07:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Phase 3 TOPAZ-1 trial of AstraZeneca's durvalumab demonstrates an improved overall survival benefit.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here